proactiveinvestors.com
Bright Mind Biosciences shares surge on positive epilepsy drug trial results
Shares of Bright Minds Biosciences Inc (NASDAQ: DRUG, CSE:DRUG) jumped almost 25% after the company announced positive topline results from its Phase 2...